Skip Navigation

Europace 2006 8(1):51-55; doi:10.1093/europace/euj014
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Höijer, C. J.
Right arrow Articles by Brandt, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Höijer, C. J.
Right arrow Articles by Brandt, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


CRT

Upgrade to biventricular pacing in patients with conventional pacemakers and heart failure: a double-blind, randomized crossover study

Carl J. Höijer*, Carl Meurling and Johan Brandt

Department of Cardiology, Heart and Lung Division, Lund University Hospital S-221 85 Lund Sweden

Aims To investigate whether patients with previously implanted conventional pacemakers and severe heart failure benefit from an upgrade to a biventricular system.

Methods and results Study inclusion criteria were New York Heart Association (NYHA) classes III and IV, dominant paced rhythm, and no left bundle branch block in the pre-pacing ECG. Ten patients with pacemakers (four VVIR due to slow atrial fibrillation and six DDDR, of which four were due to high-degree atrioventricular block and two to sinus node disease) were upgraded to a biventricular pacing (BVP) system. The median duration of pacing before the upgrade was 5.7 years. Assessments of 6-min walk test, symptom score, brain natriuretic peptide (pro-BNP), and echocardiography were made pre-operatively. After a run-in period of 1 month in BVP following the upgrade, the patients were randomized to a 2-month period in either BVP or right ventricular pacing (RVP), followed by 2 months in the other mode, in a double-blind crossover fashion. After each period, the pre-operative measurements were repeated. After study completion, patients were asked to select their preferred period. The median 6-min walking distance was significantly longer in BVP (400 m) vs. RVP (315 m), P=0.02. The symptom score was also significantly better in BVP (P=0.005). Median pro-BNP was significantly lower in BVP than in RVP, 3030 vs. 5064 ng/L (P=0.005). Six patients demanded an early crossover in RVP but none in BVP (P=0.015), and all patients except one expressed a preference for BVP. However, echo parameters did not show any significant differences between BVP and RVP. 

Conclusion Pacemaker patients with heart failure and dominant paced heart rhythm benefit substantially from an upgrade to BVP, in terms of physical performance and symptoms. The upgrade resulted in significantly improved cardiac function as reflected by reduced levels of pro-BNP.

Key Words: Biventricular pacing, Heart failure, Upgrade, Cardiac function


Corresponding author. Tel: +46 46 17 10 00; fax: +46 46 32 35 74. E-mail address: carl-johan.hoijer{at}skane.se


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
P. W.X. Foley, S. A. Muhyaldeen, S. Chalil, R. E.A. Smith, J. E. Sanderson, and F. Leyva
Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure
Europace, April 1, 2009; 11(4): 495 - 501.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G. Jauvert, J. Rousseau-Paziaud, E. Villain, L. Iserin, F. Hidden-Lucet, M. Ladouceur, and D. Sidi
Effects of cardiac resynchronization therapy on echocardiographic indices, functional capacity, and clinical outcomes of patients with a systemic right ventricle
Europace, February 1, 2009; 11(2): 184 - 190.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Kypta, C. Steinwender, J. Kammler, F. Leisch, and R. Hofmann
Long-term outcomes in patients with atrioventricular block undergoing septal ventricular lead implantation compared with standard apical pacing
Europace, May 1, 2008; 10(5): 574 - 579.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Europace, October 1, 2007; 9(10): 959 - 998.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.